Kiora Pharmaceuticals Stock Analysis

Kiora Stock Analysis Notes

About 48.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.36. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Kiora Pharmaceuticals recorded earning per share (EPS) of 16.53. The entity last dividend was issued on the 30th of August 2019. The firm had 1:9 split on the 11th of June 2024. Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Kiora Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Salt Lake City, Utah. Kiora Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 14 people. To find out more about Kiora Pharmaceuticals contact Brian Strem at 858 224 9600 or learn more at https://www.kiorapharma.com.

Kiora Pharmaceuticals Investment Alerts

Kiora Pharmaceuticals Upcoming and Recent Events

Kiora Largest EPS Surprises

View All Earnings Estimates

Kiora Pharmaceuticals Environmental, Social, and Governance (ESG) Scores

Kiora Stock Institutional Investors

Note, although Kiora Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Kiora Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 10.75 M.

Kiora Profitablity

The company has Profit Margin (PM) of 0.2 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of (121.23) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $121.23.

Management Efficiency

Kiora Pharmaceuticals has return on total asset (ROA) of 0.1296 % which means that it generated a profit of $0.1296 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1369 %, meaning that it created $0.1369 on every $100 dollars invested by stockholders. Kiora Pharmaceuticals' management efficiency ratios could be used to measure how well Kiora Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -2.41 in 2025. Return On Capital Employed is likely to rise to -1.14 in 2025. At this time, Kiora Pharmaceuticals' Other Current Assets are fairly stable compared to the past year. Total Current Assets is likely to rise to about 5.6 M in 2025, whereas Total Assets are likely to drop slightly above 11.7 M in 2025.

Technical Drivers

As of the 16th of February 2025, Kiora Pharmaceuticals secures the Risk Adjusted Performance of 0.0293, downside deviation of 4.31, and Mean Deviation of 3.18. Kiora Pharmaceuticals technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices.

Kiora Pharmaceuticals Price Movement Analysis

Kiora Pharmaceuticals Insider Trading Activities

Kiora Pharmaceuticals Outstanding Bonds

Kiora Pharmaceuticals Predictive Daily Indicators

Kiora Pharmaceuticals Corporate Filings

Kiora Pharmaceuticals Forecast Models

Kiora Pharmaceuticals' time-series forecasting models are one of many Kiora Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Kiora Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Kiora Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Kiora shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Kiora Pharmaceuticals. By using and applying Kiora Stock analysis, traders can create a robust methodology for identifying Kiora entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Kiora analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Kiora analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Kiora Pharmaceuticals stock analysis indicators help investors evaluate how Kiora Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Kiora Pharmaceuticals shares will generate the highest return on investment. By understating and applying Kiora Pharmaceuticals stock analysis, traders can identify Kiora Pharmaceuticals position entry and exit signals to maximize returns.

When running Kiora Pharmaceuticals' price analysis, check to measure Kiora Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiora Pharmaceuticals is operating at the current time. Most of Kiora Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kiora Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kiora Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kiora Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.